Merck: Vytorin helps kidney-disease patients
November 21, 2010 at 02:44 AM EST
Merck & Co. said its Vytorin cholesterol-lowering drug was shown in a study of kidney-disease patients to reduce the incidence of first major heart attacks and strokes by a “highly statistically significant” 16.1% compared with a placebo.
